|
|
|
|
|
Last Trade
|
Last Trade:
$118.04
|
Change:
7.27 (6.56%)
|
Trade Time:
04:00 PM EST
|
Market Cap:
$1.89B
|
|
|
|
|
|
|
Description of Business
|
|
We are a biopharmaceutical company focused on developing and acquiring
technologies that help pharmaceutical companies discover and develop medicines.
We employ research technologies such as antibody discovery technologies,
structure-based drug design, formulation science and liver targeted pro-drug
technologies to assist companies in their work toward securing prescription drug
and biologic approvals. We currently have partnerships and license agreements
with over 120 pharmaceutical and biotechnology companies. Over 200 different
programs are in various stages of commercialization and development and fully
funded by our collaboration partners and licensees. We have contributed novel
research and technologies for approved medicines that treat cancer,
osteoporosis, fungal infections and PPD, among others.
|
|
|
|